News Merck names new R&D chief for healthcare business Industry veteran David Weinreich will step into the top healthcare R&D role at Merck KGaA, following Danny Bar-Zohar's move to lead the division.
News Nykode changes tack after Roche exits partnership Hit by the loss of a partnership with Roche's Genentech unit last year, Norway's Nykode has narrowed its R&D focus.
R&D Sponsored Company Profile: Recursion TechBio Recursion is continuously moving toward increased AI, automation, and machine learning modelling.
News Merck has a $2bn flutter on Skyhawk's RNA platform Merck KGaA has become the latest drugmaker to partner with Skyhawk Therapeutics on its RNA splicing drug discovery engine.
News GSK forges $12bn alliance with China's Hengrui GSK has moved to shore up its R&D pipeline with a strategic-level partnering deal with China's Jiangsu Hengrui Pharma.
News AstraZeneca reveals $50bn investment in US facilities Trump's pharma tariffs haven't appeared yet, but AstraZeneca has joined several of its peers with big investments in US manufacturing and R&D.
News Agios mulls early FDA filing for sickle cell therapy Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.